Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells.

A number of strategies have been investigated to improve therapeutic vascularization of ischemic and bioengineered tissues. In these studies, we genetically modified vascular smooth muscle cells (VSMC) to promote endothelial cell proliferation, migration, and formation of microvascular networks. VSMCs were virally transduced to produce vascular endothelial growth factor (VEGF), which acts as a chemoattractant and mitogen of endothelial cells (EC). VSMCs transduced with VEGF(165) cDNA produced significant levels of the protein (2-4 ng/10(5) cell/day). The proliferation of ECs increased after exposure to VEGF-transfected SMCs or their conditioned media. The chemotactic response of ECs to the VEGF-producing cells was explored in two in vitro systems, the modified Boyden chamber assay and a 2-D fence-style migration assay, and both demonstrated increased migration of ECs in response to VEGF-transfected cells. Furthermore, endothelial cells seeded on top of the VEGF-transfected SMCs formed capillary-like structures. These results suggest that VSMCs genetically modified to produce VEGF could be a potential delivery mechanism to enhance endothelial cell migration and subsequent capillary formation, which in turn could improve vascularization of ischemic or regenerating tissue. Furthermore, this system could potentially be used as an in vitro test bed for evaluation of novel angiogenic and anti-angiogenic compounds.

[1]  P. Aebischer,et al.  Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia , 2001, Gene Therapy.

[2]  O Damour,et al.  A tissue‐engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary‐like tube formation in vitro , 2003, The British journal of dermatology.

[3]  J. Gamble,et al.  Angiogenesis: models and modulators. , 1995, International review of cytology.

[4]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[5]  A. Perets,et al.  Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.

[6]  M. del Río,et al.  A preclinical model for the analysis of genetically modified human skin in vivo. , 2002, Human gene therapy.

[7]  G. Davis,et al.  RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. , 2000, The American journal of pathology.

[8]  S. Djurovic,et al.  Variations in transfection efficiency of VEGF165 and VEGF121-cDNA , 2004, Molecular biotechnology.

[9]  Y. Uchida,et al.  Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.

[10]  J. Isner,et al.  Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[11]  T. Resink,et al.  Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. , 1989, Hypertension.

[12]  S. Stacker,et al.  Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  H. Vandenburgh,et al.  Recombinant Vascular Endothelial Growth Factor Secreted From Tissue-Engineered Bioartificial Muscles Promotes Localized Angiogenesis , 2001, Circulation.

[14]  M. Phaneuf,et al.  A biologically active VEGF construct in vitro: implications for bioengineering-improved prosthetic vascular grafts. , 2002, Journal of biomedical materials research.

[15]  Anthony Atala,et al.  Systems for therapeutic angiogenesis in tissue engineering , 2000, World Journal of Urology.

[16]  H. Blau,et al.  VEGF gene delivery to muscle: potential role for vasculogenesis in adults. , 1998, Molecular cell.

[17]  P. J. Newman,et al.  The biology of PECAM-1. , 1997, The Journal of clinical investigation.

[18]  M. Klagsbrun,et al.  Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells , 1989, The Journal of cell biology.

[19]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[20]  P. D’Amore,et al.  Cellular interactions in vascular growth and differentiation. , 2001, International review of cytology.

[21]  B. Keyt,et al.  VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. , 1996, The Journal of surgical research.

[22]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[23]  M. Gerritsen,et al.  Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. , 1999, The American journal of pathology.

[24]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.

[25]  M. Moses,et al.  Biocompatible controlled release polymers for delivery of polypeptides and growth factors , 1991, Journal of cellular biochemistry.

[26]  J. Folkman,et al.  Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. , 1994, Microvascular research.

[27]  Napoleone Ferrara,et al.  VEGF and the quest for tumour angiogenesis factors , 2002, Nature Reviews Cancer.

[28]  G. Davis,et al.  RGD-Dependent Vacuolation and Lumen Formation Observed during Endothelial Cell Morphogenesis in Three-Dimensional Fibrin Matrices Involves the αvβ3 and α5β1 Integrins , 2000 .

[29]  T. Takato,et al.  Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. , 2004, Cardiovascular research.

[30]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[31]  G. Stark,et al.  Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. , 2003, Tissue engineering.

[32]  H. Vandenburgh,et al.  Therapeutic Potential of Implanted Tissue‐Engineered Bioartificial Muscles Delivering Recombinant Proteins to the Sheep Heart , 2002, Annals of the New York Academy of Sciences.

[33]  David J Mooney,et al.  Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.

[34]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[35]  J. Isner,et al.  Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. , 1995, Journal of vascular surgery.

[36]  J. Isner,et al.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.

[37]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[38]  D. Darland,et al.  Cell-cell interactions in vascular development. , 2001, Current topics in developmental biology.

[39]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[40]  S. Rafii,et al.  Circulating endothelial precursors: mystery, reality, and promise. , 2000, The Journal of clinical investigation.

[41]  Y. M. Elçin,et al.  Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. , 2001, Artificial organs.